Indaptus raises ~$3M in registered direct offering and warrant private placement

Indaptus Therapeutics, Inc.

Gross proceeds ~$3.0M from sale of 1,643,837 shares and warrants to purchase same number of shares.
Combined purchase price $1.825 per share and warrant; warrant exercise price $1.70, 5-year term.
CEO participating, purchasing 84,932 shares and warrants on same terms.
Closing expected August 8, 2024; net proceeds for R&D and working capital.
Paulson Investment Company acted as placement agent with 9% cash fee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.